We are Renalytix.

Our singular goal is to
eradicate kidney disease.


Kidney disease affects more people than cancer and heart disease combined.

850 million people worldwide suffer with chronic kidney disease (CKD). And it is believed that CKD will become the 5th leading cause of death in the world by 2040.

To turn the corner, we must shift the focus from kidney disease to kidney health.

Only then can we chart a new and, more clinically- and cost-effective path forward.

Another medical breakthrough.

Incredibly, scientists have learned how to edit genes to decrease chronic illness. They’ve invented medications to prevent the spread of deadly diseases, like HIV. They’ve even discovered multiple COVID-19 vaccines in less than one year. And now, we are proud to join that list of important medical breakthroughs.

KidneyIntelX™

Recognized by the FDA with Breakthrough Designation

Our KidneyIntelX test provides clinicians with tools to understand individual patient risk for kidney disease progression. It further provides actionable, segmented treatment insights.

Join our growing roster
of world-class partners.

Let’s stand together to change the lives of so many.

Mount Sinai
University of Michigan
University of Utah
AstraZeneca
National Kidney Foundation


Featured in Diabetologia.

And in these prominent publications.